Telomir Pharmaceuticals(TELO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

TELO Telomir Pharmaceuticals

休市中 02-06 16:00:00 EST

1.15

+0.03

+2.68%

盘后1.14

-0.01-0.87%

19:55 EST

最高1.19	最低1.11	成交量12.01万
今开1.11	昨收1.12	日振幅7.14%
总市值3,954万	流通市值1,763万	总股本3,438万
成交额13.85万	换手率0.78%	流通股本1,533万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"TELO","market":"US","secType":"STK","nameCN":"Telomir Pharmaceuticals","latestPrice":1.15,"timestamp":1770411600000,"preClose":1.12,"halted":0,"volume":120082,"hourTrading":{"tag":"盘后","latestPrice":1.14,"preClose":1.15,"latestTime":"19:55 EST","volume":795,"amount":918.82,"timestamp":1770425745824,"change":-0.01,"changeRate":-0.008696,"amplitude":0.026087},"delay":0,"changeRate":0.026785714285714107,"floatShares":15328300,"shares":34380971,"eps":-0.366519,"marketStatus":"休市中","change":0.03,"latestTime":"02-06 16:00:00 EST","open":1.11,"high":1.19,"low":1.11,"amount":138532.239054,"amplitude":0.071429,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.366519,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"listingDate":1707454800000,"exchange":"NASDAQ","adjPreClose":1.12,"preHourTrading":{"tag":"盘前","latestPrice":1.1,"preClose":1.12,"latestTime":"09:18 EST","volume":207,"amount":228.05001629999998,"timestamp":1770387533408,"change":-0.02,"changeRate":-0.017857,"amplitude":0.044643},"postHourTrading":{"tag":"盘后","latestPrice":1.14,"preClose":1.15,"latestTime":"19:55 EST","volume":795,"amount":918.82,"timestamp":1770425745824,"change":-0.01,"changeRate":-0.008696,"amplitude":0.026087},"volumeRatio":0.507703},"requestUrl":"/m/hq/s/TELO","defaultTab":"news","newsList":[{"id":"1112118530","title":"Telomir Pharmaceuticals：Telomir-1在侵袭性三阴性乳腺癌动物模型中显著抑制肿瘤生长与转移","url":"https://stock-news.laohu8.com/highlight/detail?id=1112118530","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1112118530?lang=zh_cn&edition=full","pubTime":"2026-01-05 21:08","pubTimestamp":1767618492,"startTime":"0","endTime":"0","summary":"在针对侵袭性三阴性乳腺癌的临床前研究中，Telomir Pharmaceuticals公司研发的候选药物Telomir-1展现出令人瞩目的抗肿瘤活性。实验数据显示，该药物能显著减缓肿瘤的生长速度，并有效抑制癌细胞的远端转移。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TELO"],"gpt_icon":0},{"id":"1120352687","title":"Telomir Pharmaceuticals：Loi规定向Teli股东发行的Telomir股票需锁定6个月","url":"https://stock-news.laohu8.com/highlight/detail?id=1120352687","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1120352687?lang=zh_cn&edition=full","pubTime":"2025-10-21 06:08","pubTimestamp":1760998125,"startTime":"0","endTime":"0","summary":"Telomir Pharmaceuticals：Loi规定向Teli股东发行的Telomir股票需锁定6个月","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TELO","BK4007"],"gpt_icon":0},{"id":"1151299086","title":"Telomir Pharmaceuticals：10月17日签署意向书，通过股票置换收购Teli Pharmaceuticals所有股份 - SEC文件","url":"https://stock-news.laohu8.com/highlight/detail?id=1151299086","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1151299086?lang=zh_cn&edition=full","pubTime":"2025-10-21 06:04","pubTimestamp":1760997848,"startTime":"0","endTime":"0","summary":"Telomir Pharmaceuticals：10月17日签署意向书，通过股票置换收购Teli Pharmaceuticals所有股份 - SEC文件","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TELO","BK4007"],"gpt_icon":0},{"id":"2576101702","title":"Telomir Pharmaceuticals, Inc.盘中异动 快速下挫5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2576101702","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576101702?lang=zh_cn&edition=full","pubTime":"2025-10-17 00:28","pubTimestamp":1760632096,"startTime":"0","endTime":"0","summary":"北京时间2025年10月17日00时28分，Telomir Pharmaceuticals, Inc.股票出现波动，股价快速跳水5.11%。Telomir Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.00%。Telomir Pharmaceuticals, Inc.公司简介：Telomir Pharmaceuticals Inc是一家领先的临床前阶段制药公司，引领着年龄逆转科学的发展。Telomir正在对早衰症、糖尿病、癌症、阿尔茨海默病、骨关节炎和其他疾病进行临床前研究。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101700281694cd591a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101700281694cd591a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TELO"],"gpt_icon":0},{"id":"1111836135","title":"Telomir Pharmaceuticals计划扩大研究范围至胰腺癌和白血病模型，并开展更多动物实验以提交IND申请——SEC文件","url":"https://stock-news.laohu8.com/highlight/detail?id=1111836135","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111836135?lang=zh_cn&edition=full","pubTime":"2025-10-09 04:11","pubTimestamp":1759954274,"startTime":"0","endTime":"0","summary":"据SEC文件显示，Telomir Pharmaceuticals计划将研究范围扩展至胰腺癌和白血病模型，并将进行更多动物实验，为提交新药研究申请(IND)做准备。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TELO","BK4007"],"gpt_icon":0},{"id":"1184402809","title":"Telomir Pharmaceuticals：Telomir-1药物可选择性杀灭侵袭性三阴性乳腺癌细胞","url":"https://stock-news.laohu8.com/highlight/detail?id=1184402809","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1184402809?lang=zh_cn&edition=full","pubTime":"2025-10-09 04:06","pubTimestamp":1759953992,"startTime":"0","endTime":"0","summary":"Telomir Pharmaceuticals公司宣布，其研发的Telomir-1药物能够选择性杀灭侵袭性三阴性乳腺癌细胞，这一发现为治疗这种难治性癌症提供了新的希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TELO","BK4007"],"gpt_icon":0},{"id":"1124222163","title":"Telomir Pharmaceuticals：Telomir-1药物可重置DNA甲基化并恢复肿瘤抑制因子功能——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1124222163","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1124222163?lang=zh_cn&edition=full","pubTime":"2025-10-07 04:06","pubTimestamp":1759781203,"startTime":"0","endTime":"0","summary":"根据SEC文件披露，Telomir Pharmaceuticals表示，其研发的Telomir-1药物能够重置DNA甲基化，从而恢复肿瘤抑制因子的功能。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TELO","BK4007"],"gpt_icon":0},{"id":"1100700361","title":"Telomir Pharmaceuticals - 体外数据显示Telomir-1可靶向更多组蛋白去甲基化酶 - SEC文件","url":"https://stock-news.laohu8.com/highlight/detail?id=1100700361","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100700361?lang=zh_cn&edition=full","pubTime":"2025-09-18 19:36","pubTimestamp":1758195417,"startTime":"0","endTime":"0","summary":"Telomir Pharmaceuticals - 体外数据显示Telomir-1可靶向更多组蛋白去甲基化酶 - SEC文件","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TELO","BK4007"],"gpt_icon":0},{"id":"2558612842","title":"Telomir Pharmaceuticals, Inc.8月11日成交额为30.45万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558612842","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558612842?lang=zh_cn&edition=full","pubTime":"2025-08-12 15:09","pubTimestamp":1754982564,"startTime":"0","endTime":"0","summary":"美东时间2025年8月11日，Telomir Pharmaceuticals, Inc.成交额为30.45万美元，成交额较昨日减少63.43%，当日成交量为19.33万股。Telomir Pharmaceuticals, Inc.于2025年8月11日涨1.28%，报1.58美元，该股过去5个交易日跌13.66%，年初至今跌61.65%，过去60日跌40.6%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-11|30.45万|-63.43%|19.33万|#|2025-08-08|83.28万|15.19%|51.51万|#|2025-08-07|72.30万|77.74%|42.68万|#|2025-08-06|40.68万|35.21%|22.35万|#|2025-08-05|30.09万|-36.84%|16.59万|Telomir Pharmaceuticals Inc是一家领先的临床前阶段制药公司，引领着年龄逆转科学的发展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812150927a6e11894&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812150927a6e11894&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TELO","BK4007"],"gpt_icon":0},{"id":"2517604549","title":"Telomir Pharmaceuticals, Inc.盘中异动 急速下跌5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517604549","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517604549?lang=zh_cn&edition=full","pubTime":"2025-03-05 01:01","pubTimestamp":1741107718,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日01时01分，Telomir Pharmaceuticals, Inc.股票出现波动，股价大幅下跌5.11%。Telomir Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.16%。Telomir Pharmaceuticals, Inc.公司简介：Telomir Pharmaceuticals Inc是一家领先的临床前阶段制药公司，引领着年龄逆转科学的发展。Telomir正在对早衰症、糖尿病、癌症、阿尔茨海默病、骨关节炎和其他疾病进行临床前研究。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305010159a25f2dcd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305010159a25f2dcd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TELO"],"gpt_icon":0},{"id":"2514330909","title":"Telomir Pharmaceuticals, Inc.盘中异动 临近收盘股价大跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514330909","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514330909?lang=zh_cn&edition=full","pubTime":"2025-02-28 04:58","pubTimestamp":1740689885,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日04时58分，Telomir Pharmaceuticals, Inc.股票出现波动，股价急速下挫5.10%。Telomir Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.54%。Telomir Pharmaceuticals, Inc.公司简介：Telomir Pharmaceuticals Inc是一家领先的临床前阶段制药公司，引领着年龄逆转科学的发展。Telomir正在对早衰症、糖尿病、癌症、阿尔茨海默病、骨关节炎和其他疾病进行临床前研究。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280458069632f6da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280458069632f6da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TELO","BK4007"],"gpt_icon":0},{"id":"2514015502","title":"Telomir Pharmaceuticals, Inc.盘中异动 股价大跌5.66%报4.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514015502","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514015502?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:14","pubTimestamp":1740496471,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时14分，Telomir Pharmaceuticals, Inc.股票出现异动，股价快速下挫5.66%。Telomir Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.82%。其相关个股中，Silexion Therapeutics Corp、Abpro Holdings Inc C/Wts 12/11/2029 、Tc Biopharm  Plc C/Wts 10/02/2028 涨幅较大，Gt Biopharma, Inc.、Moleculin Biotech, Inc.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为1047.09%、584.79%、542.75%，振幅较大的相关个股有Adial Pharmaceuticals, Inc、Silexion Therapeutics Corp、Gri Bio, Inc.，振幅分别为63.66%、61.16%、56.51%。Telomir Pharmaceuticals, Inc.公司简介：Telomir Pharmaceuticals Inc是一家领先的临床前阶段制药公司，引领着年龄逆转科学的发展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502252314329892566e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502252314329892566e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TELO"],"gpt_icon":0},{"id":"2513727952","title":"Telomir Pharmaceuticals, Inc.盘中异动 早盘股价大涨6.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513727952","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513727952?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:31","pubTimestamp":1740407485,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时31分，Telomir Pharmaceuticals, Inc.股票出现波动，股价大幅拉升6.14%。Telomir Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.12%。Telomir Pharmaceuticals, Inc.公司简介：Telomir Pharmaceuticals Inc是一家领先的临床前阶段制药公司，引领着年龄逆转科学的发展。Telomir正在对早衰症、糖尿病、癌症、阿尔茨海默病、骨关节炎和其他疾病进行临床前研究。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242231269890f572&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242231269890f572&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TELO","BK4007"],"gpt_icon":0},{"id":"2513921960","title":"Telomir Pharmaceuticals, Inc.盘中异动 下午盘急速下跌5.02%报3.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513921960","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513921960?lang=zh_cn&edition=full","pubTime":"2025-02-22 03:02","pubTimestamp":1740164575,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日03时02分，Telomir Pharmaceuticals, Inc.股票出现波动，股价快速跳水5.02%。Telomir Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.39%。Telomir Pharmaceuticals, Inc.公司简介：Telomir Pharmaceuticals Inc是一家领先的临床前阶段制药公司，引领着年龄逆转科学的发展。Telomir正在对早衰症、糖尿病、癌症、阿尔茨海默病、骨关节炎和其他疾病进行临床前研究。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222030255988e1713&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222030255988e1713&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TELO","BK4007"],"gpt_icon":0},{"id":"2512433911","title":"Telomir Pharmaceuticals, Inc.盘中异动 股价大涨5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512433911","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512433911?lang=zh_cn&edition=full","pubTime":"2025-02-20 02:31","pubTimestamp":1739989893,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日02时31分，Telomir Pharmaceuticals, Inc.股票出现异动，股价快速拉升5.36%。Telomir Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.48%。Telomir Pharmaceuticals, Inc.公司简介：Telomir Pharmaceuticals Inc是一家处于临床前阶段的先锋制药公司，引领抗衰老科学的发展。通过在细胞层面解决衰老的根本原因，Telomir旨在解决这些疾病的根源，而不仅仅是治疗症状。Telomir正在对早衰症、糖尿病、癌症、阿尔茨海默病、骨关节炎等进行持续的临床前研究。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220023133988b57db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220023133988b57db&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TELO"],"gpt_icon":0},{"id":"2512416526","title":"Telomir Pharmaceuticals, Inc.盘中异动 股价大跌5.36%报4.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512416526","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512416526?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:35","pubTimestamp":1739889322,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时35分，Telomir Pharmaceuticals, Inc.股票出现异动，股价急速跳水5.36%。Telomir Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。Telomir Pharmaceuticals, Inc.公司简介：Telomir Pharmaceuticals Inc是一家处于临床前阶段的先锋制药公司，引领抗衰老科学的发展。通过在细胞层面解决衰老的根本原因，Telomir旨在解决这些疾病的根源，而不仅仅是治疗症状。Telomir正在对早衰症、糖尿病、癌症、阿尔茨海默病、骨关节炎等进行持续的临床前研究。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182235229889fd78&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182235229889fd78&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TELO","BK4007"],"gpt_icon":0},{"id":"2510328893","title":"Telomir Pharmaceuticals, Inc.盘中异动 股价大涨6.18%报4.64美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510328893","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510328893?lang=zh_cn&edition=full","pubTime":"2025-02-11 01:36","pubTimestamp":1739208979,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日01时36分，Telomir Pharmaceuticals, Inc.股票出现异动，股价大幅拉升6.18%。Telomir Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.06%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Biodexa Pharmaceuticals Plc、Dominari Holdings Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Nls Pharmaceutics Ltd.、Ocean Biomedical, Inc.较为活跃，换手率分别为2983.07%、1609.33%、1188.57%，振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Abpro Holdings Inc C/Wts 12/11/2029 、Ocean Biomedical, Inc.，振幅分别为99.86%、87.80%、85.48%。Telomir Pharmaceuticals, Inc.公司简介：Telomir Pharmaceuticals Inc是一家处于临床前阶段的先锋制药公司，引领抗衰老科学的发展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021101361998809c05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021101361998809c05&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TELO","BK4007"],"gpt_icon":0},{"id":"2508142502","title":"Telomir Pharmaceuticals, Inc.盘中异动 早盘快速跳水5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508142502","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508142502?lang=zh_cn&edition=full","pubTime":"2025-02-03 23:17","pubTimestamp":1738595825,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日23时17分，Telomir Pharmaceuticals, Inc.股票出现异动，股价快速下跌5.35%。Telomir Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.25%。Telomir Pharmaceuticals, Inc.公司简介：Telomir Pharmaceuticals Inc是一家处于临床前阶段的先锋制药公司，引领抗衰老科学的发展。通过在细胞层面解决衰老的根本原因，Telomir旨在解决这些疾病的根源，而不仅仅是治疗症状。Telomir正在对早衰症、糖尿病、癌症、阿尔茨海默病、骨关节炎等进行持续的临床前研究。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203231705abc1112d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203231705abc1112d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TELO","BK4007"],"gpt_icon":0},{"id":"2507666269","title":"Telomir Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.09%报4.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507666269","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507666269?lang=zh_cn&edition=full","pubTime":"2025-01-31 22:43","pubTimestamp":1738334637,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日22时43分，Telomir Pharmaceuticals, Inc.股票出现异动，股价大幅上涨5.09%。Telomir Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.88%。Telomir Pharmaceuticals, Inc.公司简介：Telomir Pharmaceuticals Inc是一家处于临床前阶段的先锋制药公司，引领抗衰老科学的发展。通过在细胞层面解决衰老的根本原因，Telomir旨在解决这些疾病的根源，而不仅仅是治疗症状。Telomir正在对早衰症、糖尿病、癌症、阿尔茨海默病、骨关节炎等进行持续的临床前研究。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501312243579614ec9c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501312243579614ec9c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TELO","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.telomirpharma.com","stockEarnings":[{"period":"1week","weight":0.0088},{"period":"1month","weight":-0.215},{"period":"3month","weight":-0.1221},{"period":"6month","weight":-0.2628},{"period":"1year","weight":-0.7456},{"period":"ytd","weight":-0.1353}],"compareEarnings":[{"period":"1week","weight":-0.002},{"period":"1month","weight":0.0015},{"period":"3month","weight":0.0293},{"period":"6month","weight":0.0839},{"period":"1year","weight":0.139},{"period":"ytd","weight":0.0128}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Telomir Pharmaceuticals, Inc.于2021年8月成立为佛罗里达州的一家公司。该公司是一家临床前阶段制药公司，专注于TELOMIR-1的开发和商业化，TELOMIR-1是一种正在开发的新型小分子，可作为人类干细胞的口服原位治疗性治疗。原位干细胞疗法利用人体的自然资源来再生受损组织，并用新的功能性细胞取代细胞。","exchange":"NASDAQ","name":"Telomir Pharmaceuticals","nameEN":"Telomir Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Telomir Pharmaceuticals(TELO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Telomir Pharmaceuticals(TELO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Telomir Pharmaceuticals,TELO,Telomir Pharmaceuticals股票,Telomir Pharmaceuticals股票老虎,Telomir Pharmaceuticals股票老虎国际,Telomir Pharmaceuticals行情,Telomir Pharmaceuticals股票行情,Telomir Pharmaceuticals股价,Telomir Pharmaceuticals股市,Telomir Pharmaceuticals股票价格,Telomir Pharmaceuticals股票交易,Telomir Pharmaceuticals股票购买,Telomir Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Telomir Pharmaceuticals(TELO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Telomir Pharmaceuticals(TELO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}